This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n10http://linked.opendata.cz/resource/drugbank/drug/DB06836/identifier/pdb/
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n13http://linked.opendata.cz/resource/drugbank/drug/DB06836/identifier/pubchem-compound/
n14http://linked.opendata.cz/resource/drugbank/drug/DB06836/identifier/pubchem-substance/
n9http://linked.opendata.cz/resource/drugbank/drug/DB06836/identifier/drugbank/
n12http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n11http://linked.opendata.cz/resource/drugbank/drug/DB06836/identifier/chemspider/
n6http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB06836
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB06836 n12:DB06836
dcterms:title
N-(5-(4-CHLORO-3-(2-HYDROXY-ETHYLSULFAMOYL)- PHENYLTHIAZOLE-2-YL)-ACETAMIDE
adms:identifier
n9:DB06836 n10:093 n11:5254622 n13:6852167 n14:99443307
n3:IUPAC-Name
n4:271B5692-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B5698-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B5697-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B5694-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B5695-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B5696-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B5690-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B5691-363D-11E5-9242-09173F13E4C5 n4:271B568E-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B568F-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B569E-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B569F-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B5699-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B569A-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B569C-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B569B-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B569D-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B56A4-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B56A6-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B56A7-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B56A3-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B56A2-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B56A5-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B5693-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B56A0-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B56A1-363D-11E5-9242-09173F13E4C5